Crizotinib exhibits antitumor activity by targeting ALK signaling not c-MET in pancreatic cancer
about
Novel agents for advanced pancreatic cancerRoles of c-Met and RON kinases in tumor progression and their potential as therapeutic targetsForetinib inhibits angiogenesis, lymphangiogenesis and tumor growth of pancreatic cancer in vivo by decreasing VEGFR-2/3 and TIE-2 signaling.Nicotine Reduces Survival via Augmentation of Paracrine HGF-MET Signaling in the Pancreatic Cancer MicroenvironmentPancreatic stellate cell: Pandora's box for pancreatic disease biology.[Clinical Advanced in Early-stage ALK-positive Non-small Cell Lung Cancer Patients].
P2860
Crizotinib exhibits antitumor activity by targeting ALK signaling not c-MET in pancreatic cancer
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Crizotinib exhibits antitumor ...... not c-MET in pancreatic cancer
@ast
Crizotinib exhibits antitumor ...... not c-MET in pancreatic cancer
@en
Crizotinib exhibits antitumor ...... not c-MET in pancreatic cancer
@nl
type
label
Crizotinib exhibits antitumor ...... not c-MET in pancreatic cancer
@ast
Crizotinib exhibits antitumor ...... not c-MET in pancreatic cancer
@en
Crizotinib exhibits antitumor ...... not c-MET in pancreatic cancer
@nl
prefLabel
Crizotinib exhibits antitumor ...... not c-MET in pancreatic cancer
@ast
Crizotinib exhibits antitumor ...... not c-MET in pancreatic cancer
@en
Crizotinib exhibits antitumor ...... not c-MET in pancreatic cancer
@nl
P2093
P2860
P356
P1433
P1476
Crizotinib exhibits antitumor ...... not c-MET in pancreatic cancer
@en
P2093
Hong Hua Yan
Juyoung Kim
Kyung Hee Jung
Mi Kwon Son
Mi-Hyun Kim
Soo Jung Kim
Soon-Sun Hong
Ye-Lim Ryu
Zhenghuan Fang
P2860
P304
P356
10.18632/ONCOTARGET.2363
P407
P577
2014-10-01T00:00:00Z